Back to News
Market Impact: 0.3
Calidi Put On Notice By NYSE For Non-Compliance In Stockholders' Equity; Shares Fall By 5%
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationCompany Fundamentals
Calidi Biotherapeutics received a NYSE American non-compliance notice over a deficiency in stockholder equity. The listing-compliance issue creates a potential risk to the company’s exchange listing and highlights balance-sheet pressure, although the article provides no financial magnitude or remediation plan.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CLDI-0.75
More News
- Trump says he approved new fuel economy standards rolling back Biden-era rules
- Trump’s new Medicaid rules will kick in, and GOP states are tougher. Someone may be too frail to work but can’t afford to see a doctor to prove it
- Boeing flags 737 Max software glitch affecting some automated approach functions
- OpenAI expands review of model behavior after more rogue agent incidents emerge
- Trump says he is rolling back Biden-era US fuel economy rules for cars
- China consumer stocks near decade lows as investors pile into AI